Advising leaders on the business of global health

Avenir focuses on the hard business decisions at the heart of global health. We work with CEOs and senior teams across public agencies, life science and medtech companies, and funders to decide where to focus, unlock and deploy value in the right markets, and use sharp market intelligence and negotiation‑ready frameworks to build partnerships and coalitions that are optimized for impact and built to last.

About us →

News and updates

  • Last year we launched Avenir to support leaders across life sciences and global health to connect strategy, markets, and partnerships. Outcomes of our work in 2025 included:

    • Corporate development and 150M USD capital campaign established for a global health foundation.

    • Global access and commercial pathways for emerging infectious‑disease biotech assets.

    • Strategic advisory for biopharma public benefit corporations on portfolio strategy, business development, and partnerships.

    • Leadership and negotiation counsel for senior global health executives at key inflection points.

    • HMS Summit on Clinical AI and Global Health: Co‑sponsored and spoke on financing, health equity, and brand strategy for clinical AI in underserved settings.

    • HBS Healthcare Alumni Association Annual Meeting: Opening remarks introducing 2025 Ellerin Award Recipient and maternal health activist Christy Turlington Burns and moderated a panel on women’s health with operators and investors.

    • Dartmouth: Lectures on global access, and stakeholder alignment; and on vaccines, drugs, entrepreneurship, and negotiation.

    • Health Incubator Helsinki: Session for health‑tech founders on investor storytelling and negotiation strategy.

    • HBSHAA Virtual Roundtable: Moderated a biotech roundtable on moving from concept to company.

    See more events and resources here.

Unlocking value. For good.

Avenir is not a traditional consulting shop, implementer, or advocacy group (though we work with all three). We get called in by senior teams for the gray‑area problems—where the signals are mixed, the tradeoffs are real, and the stakes are high—and help leaders turn promising ideas and relationships into concrete decisions, deals, and coalitions that lead to real world impact.

Rooted in experience across biopharma, global health, finance, and public-sector delivery, Avenir works alongside senior teams at moments of inflection: shaping narratives, structuring deals, and navigating high-stakes negotiations. We connect strategy to execution by bringing commercial, financial, and partnership disciplines into spaces where they are often fragmented.

Advisors who’ve sat in your seat.

We’ve spent our careers “in the room where it happened” across ministries, funders, industry, and global health organizations, supporting CEOs and senior teams when strategy, markets, and execution come together. Avenir now brings that experience to your toughest calls.

Example focus areas

Access models

• Help you decide where to focus and which access models make sense for priority markets

Strategy setting

• Align programs, strategies, and capital behind a coherent, defensible direction

Capital plan

• Design funding and partnerships that move capital and influence, and redistribute shared risks

Negotiations

• Equip principals and partners for high‑stakes negotiations and the conversations that follow

Partner with us →